Cryptogenic stroke. Part 2: paradoxical embolism

Cryptogenic stroke (CS) is defined as a subtype of stroke associated with a heterogeneous group of pathogenetic mechanisms that remained undetermined in the course of advanced diagnostic research. One third or fourth of the ischemic strokes is cryptogenic. Paradoxical embolism is considered the important cause of cryptogenic stroke and transient ischaemic attack (TIA) in young patients. It may occur via the following: patent foramen ovale (PFO), atrial septal defect (ASD), and pulmonary arteriovenous malformation (PAVM). When interviewing patients with suspected paradoxical embolism to obtain their health history, a practitioner should consider factors associated with Valsalva maneuvers, deep vein thrombosis/PE or predisposing conditions or situations, as well as symptoms of hereditary hemorrhagic telangiectasia (telangiectasia of the skin and mucous membranes, hemorrhagic syndrome) and pulmonary arteriovenous malformations (PAVMs) (shortness of breath, hemoptysis). If paradoxical embolism is suspected, it is necessary to conduct a stepwise diagnostic search, including transcranial Doppler ultrasound with bubble test, contrast-enhanced transesophageal echocardiography, and CT angiopulmonography. Diagnosis of relevant clinical conditions involves a search of atrial tachyarrhythmias, deep vein thrombosis, and thrombophilia. As the pathogenetic role of ASD and PAVMs in the development of embolic cryptogenic stroke is beyond doubt, the clinical significance of PFO should be determined taking into account several factors, including the presence of deep vein thrombosis/PE, the severity of the right-left shunt, the presence of ASD, the RoPE score, and detection of thrombophilia. The secondary prevention techniques of ischemic stroke or TIA with underlying PFO should be selected on a case-by-case basis, depending on the clinical significance of the anomaly, comorbid pathology, life expectancy of the patient: endovascular occlusion, anticoagulant or antiplatelet therapy. The secondary prevention with underlying ASD and LAVM includes surgical techniques such as endovascular occlusion or open surgery followed by monitoring of their effectiveness.

1. Kulesh A.A., Syromyatnikova L.I., Drobakha V.E., Mekhryakov S.A., Shestakov V.V. Cryptogenic stroke. Мoscow: GEHOTAR-Media; 2020. 128 p. (In Russ.) https://doi.org/10.33029/9704-5597-5-CS-2020-1-128.

2. Kulesh A.A., Drobakha V.E., Shestakov V.V. Cryptogenic stroke. Nevrologiya, neyropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(4):14–21. (In Russ.) https://doi.org/10.14412/2074-2711-2019-4-14-21.

3. Ntaios G. Embolic Stroke of Undetermined Source: JACC Review Topic of the Week. J Am Coll Cardiol. 2020;75(3):333–340. https://doi.org/10.1016/j.jacc.2019.11.024.

4. Hart R.G., Diener H.C., Coutts S.B., Easton J.D., Granger C.B., O’Donnell M.J. et al. Cryptogenic Stroke/ESUS International Working Group. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014;13(4):429–438. https://doi.org/10.1016/S1474-4422(13)70310-7.

5. Mekhryakov S.A., Kulesh A.A., Syromyatnikova L.I., Sobyanin К.V. Biomarkers of atrial cardiopathy in patients with different pathogenetic subtypes of ischemic stroke. Nevrologiya, neyropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020;12(6):33–41. (In Russ.) https://doi.org/10.14412/2074-2711-2020-6-33-41.

6. Kulesh A.A., Demin D.A., Vinogradov O.I. Cryptogenic stroke. Part 1: Aorto-arterial embolism. Meditsinskiy sovet = Medical Council. 2021;(4):78–87. (In Russ.) https://doi.org/10.21518/2079-701X-2021-4-78-87.

7. Renna R., Pilato F., Profice P., Della Marca G., Broccolini A., Morosetti R. et al. Risk factor and etiology analysis of ischemic stroke in young adult patients. J Stroke Cerebrovasc Dis. 2014;23(3):e221-e227. https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.10.008.

8. Kulesh A.A., Nurieva Yu.A., Syromyatnikova L.I. Causes of ischemic stroke in patients younger than 45 years: analysis of data from the regional vascular center. Nevrologiya, neyropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2021;13(1):24–30. (In Russ.) https://doi.org/10.14412/2074-2711-2021-1-24-30.

9. Saver J.L., Mattle H.P., Thaler D. Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Ischemic Stroke: A Topical Review. Stroke. 2018;49(6):1541–1548. https://doi.org/10.1161/STROKEAHA.117.018153.

10. Mojadidi M.K., Zaman M.O., Elgendy I.Y., Mahmoud A.N., Patel N.K., Agarwal N. et al. Cryptogenic Stroke and Patent Foramen Ovale. J Am Coll Cardiol. 2018;71(9):1035–1043. https://doi.org/10.1016/j.jacc.2017.12.059.

11. Kulesh A.A., Shestakov V.V. Patent foramen ovale and embolic cryptogenic stroke. Nevrologiya, neyropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(2):4–11. (In Russ.) https://doi.org/10.14412/2074-2711-2019-2-4-11.

12. Kulesh A.A., Ognerubov D.V., Mekhryakov S.A., Merkulov E.V., Syromyatnikova L.I., Tereshchenko A.S., et al. Patent foramen ovalerelated stroke: diagnostic approaches and the possibility of endovascular prophylaxis (clinical cases and literature review). Nevrologiya, neyropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020;12(2):72–78. (In Russ.) https://doi.org/10.14412/2074-2711-2020-2-72-78.

13. Geva T., Martins J.D., Wald R.M. Atrial septal defects. Lancet. 2014;383(9932):1921–1932. https://doi.org/10.1016/S0140-6736(13)62145-5.

14. Naqvi N., McCarthy K. P., Ho S.Y. Anatomy of the atrial septum and interatrial communications. J Thorac Dis. 2018;10(24 Suppl.):S2837-S2847. https://doi.org/10.21037/jtd.2018.02.18.

15. Saric M., Armour A.C., Arnaout M.S., Chaudhry F.A., Grimm R.A., Kronzon I. et al. Guidelines for the Use of Echocardiography in the Evaluation of a Cardiac Source of Embolism. J Am Soc Echocardiogr. 2016;29(1):1–42. https://doi.org/10.1016/j.echo.2015.09.011.

16. Silvestry F.E., Cohen M.S., Armsby L.B., Burkule N.J., Fleishman C.E., Hijazi Z.M. et al. Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. J Am Soc Echocardiogr. 2015;28(8):910–958. https://doi.org/10.1016/j.echo.2015.05.015.

17. Ewert P., Berger F., Vogel M., Dähnert I., Alexi-Meshkishvili V., Lange P.E. Morphology of perforated atrial septal aneurysm suitable for closure by transcatheter device placement. Heart. 2000;84(3):327–331. https://doi.org/10.1136/heart.84.3.327.

18. Nakayama M., Nawa T., Chonan T., Endo K., Morikawa S., Bando M. et al. Prevalence of Pulmonary Arteriovenous Malformations as Estimated by Low-Dose Thoracic CT Screening. Intern Med. 2012;51(13):1677–1681. https://doi.org/10.2169/internalmedicine.51.7305.

19. Saboo S.S., Chamarthy M., Bhalla S., Park H., Sutphin P., Kay F. et al. Pulmonary arteriovenous malformations: diagnosis. Cardiovasc Diagn Ther. 2018;8(3):325–337. https://doi.org/10.21037/cdt.2018.06.01.

20. Windecker S., Stortecky S., Meier B. Paradoxical embolism. J Am Coll Cardiol. 2014;64(4):403–415. https://doi.org/10.1016/j.jacc.2014.04.063.

21. Ozdemir A.O., Tamayo A., Munoz C., Dias B., Spence J.D. Cryptogenic stroke and patent foramen ovale: clinical clues to paradoxical embolism. J Neurol Sci. 2008;275(1-2):121–127. https://doi.org/10.1016/j.jns.2008.08.018.

22. Zietz A., Sutter R., De Marchis G.M. Deep Vein Thrombosis and Pulmonary Embolism Among Patients With a Cryptogenic Stroke Linked to Patent Foramen Ovale-A Review of the Literature. Front Neurol. 2020;11:336. https://doi.org/10.3389/fneur.2020.00336.

23. Schneider B., Hanrath P., Vogel P., Meinertz T. Improved morphologic characterization of atrial septal aneurysm by transesophageal echocardiography: relation to cerebrovascular events. J Am Coll Cardiol. 1990;16(4):1000–1009. https://doi.org/10.1016/s0735-1097(10)80354-7.

24. Mekhryakov S.A., Kulesh A.A., Syromyatnikova L.I. Ischemic stroke on the background of probable in situ thrombosis of atrial septal aneurysm in a patient taking hormonal contraceptives. Meditsinskiy sovet = Medical Council. 2020;(2):132–136. (In Russ.) https://doi.org/10.21518/2079-701X-2020-2-132-136.

25. Nii T., Yoshikawa H., Okabe T., Tachibana I. Septic pulmonary and systemic embolism in tricuspid endocarditis. BMJ Case Rep. 2014;2014:bcr2014206569. https://doi.org/10.1136/bcr-2014-206569.

26. Cramer S.C., Rordorf G., Maki J.H., Kramer L.A., Grotta J.C., Burgin W.S. et al. Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke. 2004;35(1):46–50. https://doi.org/10.1161/01. STR.0000106137.42649.AB.

27. DeSimone C. V., Friedman P.A., Noheria A., Patel N.A., DeSimone D. C., Bdeir S. et al. Stroke or transient ischemic attack in patients with transvenous pacemaker or defibrillator and echocardiographically detected patent foramen ovale. Circulation. 2013;128(13):1433–1441. https://doi.org/10.1161/CIRCULATIONAHA.113.003540.

28. Moradi M., Adeli M. Brain abscess as the first manifestation of pulmonary arteriovenous malformation: A case report. Adv Biomed Res. 2014;3:28. https://doi.org/10.4103/2277-9175.124677.

29. Timon C., Keady C., Murphy C.G. Fat Embolism Syndrome – A Qualitative Review of its Incidence, Presentation, Pathogenesis and Management. Malays Orthop J. 2021;15(1):1–11. https://doi.org/10.5704/MOJ.2103.001

30. McCarthy C. J., Behravesh S., Naidu S.G., Oklu R. Air Embolism: Practical Tips for Prevention and Treatment. J Clin Med. 2016;5(11):93. https://doi.org/10.3390/jcm5110093.

31. Meier B., Frank B., Wahl A., Diener H.C. Secondary stroke prevention: patent foramen ovale, aortic plaque, and carotid stenosis. Eur Heart J. 2012;33(6):705–713b. https://doi.org/10.1093/eurheartj/ehr443.

32. Koutroulou I., Tsivgoulis G., Tsalikakis D., Karacostas D., Grigoriadis N., Karapanayiotides T. Epidemiology of Patent Foramen Ovale in General Population and in Stroke Patients: A Narrative Review. Front Neurol. 2020;11:281. https://doi.org/10.3389/fneur.2020.00281.

33. Alsheikh-Ali A.A., Thaler D.E., Kent D.M. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke. 2009;40(7):2349– 2355. https://doi.org/10.1161/STROKEAHA.109.547828.

34. Diener H.C., Sacco R.L., Easton J.D., Granger C.B., Bernstein R.A., Uchiyama S. et al.; RE-SPECT ESUS Steering Committee and Investigators. Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source. N Engl J Med. 2019;380(20):1906–1917. https://doi.org/10.1056/NEJMoa1813959.

35. Hart R.G., Sharma M., Mundl H., Kasner S.E., Bangdiwala S.I., Berkowitz S.D. et al. Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. N Engl J Med. 2018;378(23):2191–2201. https://doi.org/10.1056/NEJMoa1802686.

36. Yetkin E., Atalay H., Ileri M. Atrial septal aneurysm: Prevalence and covariates in adults. Int J Cardiol. 2016;223:656–659. https://doi.org/10.1016/j.ijcard.2016.08.220.

37. Pearson A.C., Nagelhout D., Castello R., Gomez C.R., Labovitz A.J. Atrial septal aneurysm and stroke: a transesophageal echocardiographic study. J Am Coll Cardiol. 1991;18(5):1223–1229. https://doi.org/10.1016/0735-1097(91)90539-l.

38. Agmon Y., Khandheria B.K., Meissner I., Gentile F., Whisnant J.P., Sicks J.D. et al. Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation. 1999;99(15):1942–1944. https://doi.org/10.1161/01.cir.99.15.1942.

39. Cabanes L., Mas J.L., Cohen A., Amarenco P., Cabanes P.A., Oubary P. et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke. 1993;24(12):1865–1873. https://doi.org/10.1161/01.str.24.12.1865.

40. Kulesh A.A., Nurieva Yu.A., Syromyatnikova L.I. Causes of ischemic stroke in patients younger than 45 years: analysis of data from the regional vascular center. Nevrologiya, neyropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2021;13(1):24–30. https://doi.org/10.14412/2074-2711-2021-1-24-30.

41. Elgendy A.Y., Saver J.L., Amin Z., Boudoulas K.D., Carroll J.D., Elgendy I.Y. et al. Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale-Associated Stroke. JAMA Neurol. 2020;77(7):878–886. https://doi.org/10.1001/jamaneurol.2020.0458.

42. Mekhryakov S.A., Kulesh A.A., Pokalenko E.A., Syromyatnikova L.I., Kulikova S.P., Drobakha V.E. et al. The paradoxical embolism phenomenon in patients with embolic cryptogenic stroke. Nevrologiya, neyropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020;12(1):13–21. https://doi.org/10.14412/2074-2711-2020-1-13-21.

43. Ioannidis S.G., Mitsias P.D. Patent Foramen Ovale in Cryptogenic Ischemic Stroke: Direct Cause, Risk Factor, or Incidental Finding? Front Neurol. 2020;11:567. https://doi.org/10.3389/fneur.2020.00567.

44. Hoffman J.I., Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890–1900. https://doi.org/10.1016/s0735-1097(02)01886-7.

45. Lindsey J.B., Hillis L.D. Clinical update: atrial septal defects in adults. Lancet. 2007;369(9569):1244–1246. https://doi.org/10.1016/S0140-6736(07)60576-5.

46. Mügge A., Daniel W.G., Angermann C., Spes C., Khandheria B.K., Kronzon I. et al. Atrial septal aneurysm in adult patients. A multicenter study using transthoracic and transesophageal echocardiography. Circulation. 1995;91(11):2785–2792. https://doi.org/10.1161/01.cir.91.11.2785.

47. Bannan A., Shen R., Silvestry F.E., Herrmann H.C. Characteristics of adult patients with atrial septal defects presenting with paradoxical embolism. Catheter Cardiovasc Interv. 2009;74(7):1066–1069. https://doi.org/10.1002/ccd.22170.

48. Leppert M., Poisson S.N., Carroll J.D. Atrial Septal Defects and Cardioembolic Strokes. Cardiol Clin. 2016;34(2):225–230. https://doi.org/10.1016/j.ccl.2015.12.004.

49. Gatzoulis M.A., Freeman M.A., Siu S.C., Webb G.D., Harris L. Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med. 1999;340(11):839–846. https://doi.org/10.1056/NEJM199903183401103.

50. Berger F., Vogel M., Kramer A., Alexi-Meskishvili V., Weng Y., Lange P.E., Hetzer R. Incidence of atrial flutter/fibrillation in adults with atrial septal defect before and after surgery. Ann Thorac Surg. 1999;68(1):75–78. https://doi.org/10.1016/s0003-4975(99)00478-6.

51. Diller G.P., Gatzoulis M.A. Pulmonary vascular disease in adults with congenital heart disease. Circulation. 2007;115(8):1039–1050. https://doi.org/10.1161/CIRCULATIONAHA.105.592386.

52. Cottin V., Chinet T., Lavolé A., Corre R., Marchand E., Reynaud-Gaubert M. et al. Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia. Medicine (Baltimore). 2007;86(1):1–17. https://doi.org/10.1097/MD.0b013e31802f8da1.

53. Contegiacomo A., Del Ciello A., Rella R., Attempati N., Coppolino D., Larici A.R. et al. Pulmonary arteriovenous malformations: what the interventional radiologist needs to know. Radiol Med. 2019;124(10):973–988. https://doi.org/10.1007/s11547-019-01051-7.

54. Elmali M., Akan H., Findik S., Kale M., Celenk C. Hereditary Hemorrhagic Telangiectasia Associated With Pulmonary Arteriovenous Malformations Presenting as Hemothorax. J Thorac Imaging. 2008;23(4):295–297 https://doi.org/10.1097/RTI.0b013e3181820867.

55. Hoeper M.M., Krowka M.J., Strassburg C.P. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet. 2004;363(9419):1461–1468. https://doi.org/10.1016/S0140-6736(04)16107-2.

56. Wong H.H., Chan R.P., Klatt R., Faughnan M.E. Idiopathic pulmonary arteriovenous malformations: clinical and imaging characteristics. Eur Respir J. 2011;38(2):368–375. https://doi.org/10.1183/09031936.00075110.

57. Bosher L.H. Jr, Blake D.A., Byrd B.R. An analysis of the pathologic anatomy of pulmonary arteriovenous aneurysms with particular reference to the applicability of local excision. Surgery. 1959;45(1):91–104. Available at: https://pubmed.ncbi.nlm.nih.gov/13624986.

58. Vorselaars V.M., Velthuis S., Snijder R.J., Westermann C.J., Vos J.A., Mager J.J., Post M.C. Follow-up of pulmonary right-to-left shunt in hereditary haemorrhagic telangiectasia. Eur Respir J. 2016;47(6):

59. –1757. https://doi.org/10.1183/13993003.01588-2015.

60. Horner S., Niederkorn K., Gattringer T., Furtner M., Topakian R, Lang W. et al. Management of right-to-left shunt in cryptogenic cerebrovascular disease: results from the observational Austrian paradoxical cerebral embolism trial (TACET) registry. J Neurol. 2013;260(1):260–267. https://doi.org/10.1007/s00415-012-6629-9.

61. Topiwala K.K., Patel S.D., Pervez M., Shovlin C.L., Alberts M.J. Ischemic Stroke in Patients With Pulmonary Arteriovenous Fistulas. Stroke. 2021;52(7):e311-e315. https://doi.org/10.1161/STROKEAHA.120.032073.

62. Velthuis S., Buscarini E., van Gent M.W. F., Gazzaniga P., Manfredi G., Danesino C. et al. Grade of pulmonary right-to-left shunt on contrast echocardiography and cerebral complications: a striking association. Chest. 2013;144(2):542–548. https://doi.org/10.1378/chest.12-1599.

63. Pareés I., Horga A., Santamarina E., Mendióroz M., Fernández-Cádenas I., del Río-Espínola A., Alvarez-Sabín J. Stroke after prolonged air travel associated with a pulmonary arteriovenous malformation. J Neurol Sci. 2010;292(1-2):99–100. https://doi.org/10.1016/j.jns.2010.02.019.

64. Yassi N., Yan B., Dowling R., Mitchell P.J. A rare cause of embolic stroke in hereditary hemorrhagic telangiectasia. J Stroke Cerebrovasc Dis. 2014;23(5):1245–1246. https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.07.037.

65. Zanati Bazan S.G., Braga G.P., Luvizutto G.J., Trindade A.P., PontesNeto O.M., Bazan R. Bihemispheric Paradoxical Cerebral Embolism in a Patient with Pulmonary Thromboembolism and Presumptive Fistula Right-to-Left Shunt. J Stroke Cerebrovasc Dis. 2016;25(6):e95-e97. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.03.038.

66. Ng P.Y., Ng A.K., Subramaniam B., Burns S.M., Herisson F., Timm F.P. et al. Association of Preoperatively Diagnosed Patent Foramen Ovale With Perioperative Ischemic Stroke. JAMA. 2018;319(5):452–462. https://doi.org/10.1001/jama.2017.21899.

67. Snijder R.J., Luermans J.G., de Heij A.H., Thijs V., Schonewille W.J., Van De Bruaene A, Swaans M.J. et al. Patent Foramen Ovale With Atrial Septal Aneurysm Is Strongly Associated With Migraine With Aura: A Large Observational Study. J Am Heart Assoc. 2016;5(12):e003771. https://doi.org/10.1161/JAHA.116.003771.

68. West B.H., Noureddin N., Mamzhi Y., Low C.G., Coluzzi A.C., Shih E.J. et al. Frequency of Patent Foramen Ovale and Migraine in Patients With Cryptogenic Stroke. Stroke. 2018;49(5):1123–1128. https://doi.org/10.1161/STROKEAHA.117.020160.

69. Guchlerner M., Kardos P., Liss-Koch E., Franke J., Wunderlich N., Bertog S., Sievert H. PFO and right-to-left shunting in patients with obstructive sleep apnea. J Clin Sleep Med. 2012;8(4):375–380. https://doi.org/10.5664/jcsm.2026.

70. Faughnan M.E., Mager J.J., Hetts S.W., Palda V.A., Lang-Robertson K., Buscarini E. et al. Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia. Ann Intern Med. 2020;173(12):989–1001. https://doi.org/10.7326/M20-1443.

71. Shovlin C.L., Guttmacher A.E., Buscarini E., Faughnan M.E., Hyland R.H., Westermann C.J. et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000;91(1):66–67. https://doi.org/10.1002/(sici)1096-8628(20000306)91:1<66::aid-ajmg12>3.0.co;2-p.

72. Holden V.K., Shah N.G., Verceles A.C. Implications of an Incidental Pulmonary Arteriovenous Malformation. J Investig Med High Impact Case Rep. 2016;4(1):2324709616637190. https://doi.org/10.1177/2324709616637190.

73. Santamarina E., González-Alujas M.T., Muñoz V., Rovira A., Rubiera M., Ribó M. et al. Stroke patients with cardiac atrial septal abnormalities: differential infarct patterns on DWI. J Neuroimaging. 2006;16(4):334–340. https://doi.org/10.1111/j.1552-6569.2006.00056.x.

74. Nam K.W., Guk H.S., Kwon H.M., Lee Y.S. Diffusion-Weighted Imaging Patterns According to the Right-to-Left Shunt Amount in Cryptogenic Stroke. Cerebrovasc Dis. 2019;48(1-2):45–52. https://doi.org/10.1159/000502882.

75. Jauss M., Wessels T., Trittmacher S., Allendörfer J., Kaps M. Embolic lesion pattern in stroke patients with patent foramen ovale compared with patients lacking an embolic source. Stroke. 2006;37(8):2159–2161. https://doi.org/10.1161/01.STR.0000231645.22128.ab.

76. Hayashida K., Fukuchi K., Inubushi M., Fukushima K., Imakita S., Kimura K. Embolic distribution through patent foramen ovale demonstrated by (99m)Tc-MAA brain SPECT after Valsalva radionuclide venography. J Nucl Med. 2001;42(6):859–863. https://jnm.snmjournals.org/content/42/6/859.long.

77. Kim J.W., Kim S.J., Yoon C.W., Park C.H., Kang K.W., Kim S.K. et al. Association between the amount of right-to-left shunt and infarct patterns in patients with cryptogenic embolic stroke: a transcranial Doppler study. Int J Stroke. 2013;8(8):657–662. https://doi.org/10.1111/j.1747-4949.2012.00846.x.

78. Mahmoud A.N., Elgendy I.Y., Agarwal N., Tobis J.M., Mojadidi M.K. Identification and quantification of patent foramen ovale mediated shunts: echocardiography and transcranial Doppler. Interv Cardiol Clin. 2017;6(4):495–504. https://doi.org/10.1016/j.iccl.2017.05.002.

79. Gutgesell H.P., Huhta J.C., Latson L.A., Huffines D., McNamara D.G. Accuracy of two-dimensional echocardiography in the diagnosis of congenital heart disease. Am J Cardiol. 1985;55(5):514–518. https://doi.org/10.1016/0002-9149(85)90237-1.

80. Cakmak S., Goldman C., Bozio A., Nighoghossian N., Derex L., Trouillas P. Sinus venosus-type atrial septal defect: a rare curable cause of recurrent transient neurological deficits. Stroke. 2006;37(9):2385–2386. https://doi.org/10.1161/01.STR.0000236635.44539.d4.

81. Mojadidi M.K., Gevorgyan R., Tobis J.M. A comparison of methods to detect and quantitate PFO: TCD, TTE, ICE and TEE. In: Amin Z., Tobis J.M., Sievert H., Carroll J. (eds.). Patent Foramen Ovale. London: Springer; 2015. pp. 55–65. https://dx.doi.org/10.1007/978-1-4471-4987-3_7.

82. Mojadidi M.K., Zhang L., Chugh Y., Eshtehardi P., Hovnanians N., Gevorgyan R. et al. Transcranial Doppler: does addition of blood to agitated saline affect sensitivity for detecting cardiac right-to-left shunt? Echocardiography. 2016;33(8):1219–1227. https://doi.org/10.1111/echo.13231.

83. Fan S., Nagai T., Luo H., Atar S., Naqvi T., Birnbaum Y. et al. Superiority of the combination of blood and agitated saline for routine contrast enhancement. J Am Soc Echocardiogr. 1999;12:94–98. https://doi.org/10.1016/s0894-7317(99)70120-3.

84. Sun Y.P., Homma S. Patent Foramen Ovale and Stroke. Circ J. 2016;80(8):1665–1673. https://doi.org/10.1253/circj.CJ-16-0534.

85. Bang O.Y., Lee M.J., Ryoo S., Kim S.J., Kim J.W. Patent Foramen Ovale and Stroke-Current Status. J Stroke. 2015;17(3):229–237. https://doi.org/10.5853/jos.2015.17.3.229.

86. Porter T.R., Abdelmoneim S., Belcik J.T., McCulloch M. L., Mulvagh S.L., Olson J.J. et al. Guidelines for the Cardiac Sonographer in the Performance of Contrast Echocardiography: A Focused Update from the American Society of Echocardiography. J Am Soc Echocardiogr. 2014;27(8):794–810. https://doi.org/10.1016/j.echo.2014.05.011.

87. Katsanos A.H., Psaltopoulou T., Sergentanis T.N., Frogoudaki A., Vrettou A.R., Ikonomidis I. et al. Transcranial Doppler versus transthoracic echocardiography for the detection of patent foramen ovale in patients with cryptogenic cerebral ischemia: A systematic review and diagnostic test accuracy meta-analysis. Ann Neurol. 2016;79(4):625–635. https://doi.org/10.1002/ana.24609.

88. Droste D.W., Lakemeier S., Wichter T., Stypmann J., Dittrich R., Ritter M. et al. Optimizing the technique of contrast transcranial Doppler ultrasound in the detection of right-to-left shunts. Stroke. 2002;33(9):2211–2216. https://doi.org/10.1161/01.str.0000027884.03365.ac.

89. Hoksbergen A.W., Legemate D.A., Ubbink D.T., Jacobs M.J. Success rate of transcranial color-coded duplex ultrasonography in visualizing the basal cerebral arteries in vascular patients over 60 years of age. Stroke. 1999;30(7):1450–1455. https://doi.org/10.1161/01.str.30.7.1450.

90. Del Sette M., Dinia L., Rizzi D., Sugo A., Albano B., Gandolfo C. Diagnosis of Right-to-Left Shunt With Transcranial Doppler and Vertebrobasilar Recording; Stroke. 2007;38(8):2254–2256. https://doi.org/10.1161/STROKEAHA.106.479485.

91. Serena J., Segura T., Perez-Ayuso M.J. Bassaganyas J., Molins A., Dávalos A. The need to quantify right-to-left shunt in acute ischemic stroke: A case-control study. Stroke. 1998;29(7):1322–1328. https://doi.org/10.1161/01.str.29.7.1322.

92. Belopasova A.V., Dobrynina L.A., Kalashnikova L.A., Chechetkin A.O., Karshieva A.R., Abugov S.A. et al. Pulmonary arteriovenous shunt — a rare cause of recurrent stroke due to paradoxical embolism. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(9):107–113. (In Russ.) https://doi.org/10.17116/jnevro2020120091107.

93. Majumdar Sh., McWilliams J.P. Approach to pulmonary arteriovenous malformation: A comprehensive update. J Clin Med. 2020;9(6):1927. https://doi.org/10.3390/jcm9061927.

94. Chechetkin A.O., Karshieva A.R., Kravchenko M.A., Belopasova A.V., Kalashnikova L.A., Dobrynina L.A. Pulmonary arteriovenous fistula as a cause of paradoxical cerebral embolism: diagnostic ultrasound capabilities. Vestnik Rossiyskoy Voenno-meditsinskoy akademii = Bulletin of the Russian Military Medical Academy. 2019;(S3):162–164. (In Russ.) https://doi.org/10.32863/1682-7392-2019-3-67-162-164.

95. Pristipino C., Sievert H., D’Ascenzo F., Louis Mas J., Meier B., Scacciatella P. et al. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. Eur Heart J. 2019;40(38):3182–3195. https://doi.org/10.1093/eurheartj/ehy649.

96. Le Moigne E., Timsit S., Ben Salem D., Didier R., Jobic Y., Paleiron N. et al. Patent Foramen Ovale and Ischemic Stroke in Patients With Pulmonary Embolism: A Prospective Cohort Study. Ann Intern Med. 2019;170(11):756–763. https://doi.org/10.7326/M18-3485.

97. Kim Y.D., Song D., Nam H.S., Lee K., Yoo J., Hong G.R. et al. D-dimer for prediction of long-term outcome in cryptogenic stroke patients with patent foramen ovale. Thromb Haemost. 2015;114(3):614–622. https://doi.org/10.1160/TH14-12-1040.

98. Liu K., Song B., Palacios I.F., Inglessis-Azuaje I., Deng W., McMullin D. et al. Patent Foramen Ovale Attributable Cryptogenic Embolism With Thrombophilia Has Higher Risk for Recurrence and Responds to Closure. JACC Cardiovasc Interv. 2020;13(23):2745–2752. https://doi.org/10.1016/j.jcin.2020.09.059.

99. Salehi Omran S., Hartman A., Zakai N.A., Navi B.B. Thrombophilia Testing After Ischemic Stroke: Why, When, and What?. Stroke. 2021;52(5):1874–1884. https://doi.org/10.1161/STROKEAHA.120.032360.

100. Deng W., McMullin D., Inglessis-Azuaje I., Locascio J.J., Palacios I.F., Buonanno F.S. et al. Effect of Patent Foramen Ovale Closure After Stroke on Circulatory Biomarkers. Neurology. 2021;97(2):e203-e214. https://doi.org/10.1212/WNL.0000000000012188.

101. Kent D.M., Saver J.L., Ruthazer R., Furlan A.J., Reisman M., Carroll J.D. et al. Risk of Paradoxical Embolism (RoPE)-Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure: An Analysis of 3 Trials. Stroke. 2020;51(10):3119–3123. https://doi.org/10.1161/STROKEAHA.120.029350.

102. Nakayama R., Takaya Y., Akagi T., Watanabe N., Ikeda M., Nakagawa K. et al. Identification of High-Risk Patent Foramen Ovale Associated With Cryptogenic Stroke: Development of a Scoring System. J Am Soc Echocardiogr. 2019;32(7):811–816. https://doi.org/10.1016/j.echo.2019.03.021.

103. Elgendy A.Y., Elgendy I.Y., Mojadidi M.K., Mahmoud A.N., Barry J.S., Jneid H. et al. New-onset atrial fibrillation following percutaneous patent foramen ovale closure: a systematic review and meta-analysis of randomised trials. EuroIntervention. 2019;14(17):1788–1790. https://doi.org/10.4244/eij-d-18-00767.

104. Varotto L., Bregolin G., Paccanaro M., De Boni A., Bonanno C., Perini F. Network meta-analysis on patent foramen ovale: is a stroke or atrial fibrillation worse?. Neurol Sci. 2021;42(1):101–109. https://doi.org/10.1007/s10072-020-04922-4.

105. Ognerubov D.V., Tereshchenko A.S., Samko A.N., Arutyunyan G.К., Sivakova O.A., Pevzner D.V. et al. Safety and efficacy of endovascular patent foramen ovale closure: the first results of a Russian multicenter study. Nevrologiya, neyropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020;12(6):26–32. (In Russ.) https://doi.org/10.14412/2074-2711-2020-6-26-32.

106. Wintzer-Wehekind J., Alperi A., Houde C., Côté J.M., Asmarats L., Côté M., Rodés-Cabau J. Long-Term Follow-Up After Closure of Patent Foramen Ovale in Patients With Cryptogenic Embolism. J Am Coll Cardiol. 2019;73(3):278–287. https://doi.org/10.1016/j.jacc.2018.10.061.

107. Deng W., Yin S., McMullin D., Inglessis-Azuaje I., Elmariah S., Hung J. et al. Residual Shunt After Patent Foramen Ovale Closure and Long-Term Stroke Recurrence: A Prospective Cohort Study. Ann Intern Med. 2020;172(11):717–725. https://doi.org/10.7326/M19-3583.

108. Hoffmann A., Chockalingam P., Balint O.H., Dadashev A., Dimopoulos K., Engel R. et al. Cerebrovascular accidents in adult patients with congenital heart disease. Heart. 2010;96:1223–1226. https://doi.org/10.1136/hrt.2010.196147.

109. Nyboe C., Olsen M.S., Nielsen-Kudsk J.E., Hjortdal V.E. Atrial fibrillation and stroke in adult patients with atrial septal defect and long-term effect of closure. Heart. 2015;101:706–711. https://doi.org/10.1136/heartjnl-2014-306552.

110. Angelini F., Fortuni F., Tsivgoulis G., Agnelli G., Bocchino P.P., Franchin L. et al. Comparison of antithrombotic strategies in patients with cryptogenic stroke and patent foramen ovale: an updated meta-analysis. Cardiovasc Drugs Ther. 2021;35(5):987–993. https://doi.org/10.1007/s10557-020-07068-9.

111. Bobrov E.I. Pulmonary arteriovenous fistulas: diagnosis and endovascular treatment. Regionalnoe krovoobrashchenie i mikrotsirkulyatsiya = Regional Blood Circulation and Microcirculation. 2003;2(3):11–16. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=13074540.

112. Pereira-da-Silva T., Martins J.D., de Sousa L., Fiarresga A., Trigo Pereira C., Cruz Ferreira R., Ferreira Pinto F. Percutaneous occlusion of vascular malformations in pediatric and adult patients: 20-year experience of a single center. Catheter Cardiovasc Interv. 2016;87(2):E62-E68. https://doi.org/10.1002/ccd.26220.

113. Noble S., Perren F., Roffi M. Cryptogenic stroke with right-to-left shunt and no patent foramen ovale. Arch Cardiovasc Dis. 2014;107(6-7):418–419. https://doi.org/10.1016/j.acvd.2012.07.004.

114. Barbaryan A., Bailuc S., Raqeem M.W., Kak M., Derani L., Mirrakhimov A.E. Wake-Up Call: Pulmonary Arteriovenous Malformation. Am J Med. 2017;130(3):290–292. https://doi.org/10.1016/j.amjmed.2016.10.021.

115. Patti G., D’Antonio L., Sedati P., Mega S., Di Sciascio G. Percutaneous closure of a pulmonary arteriovenous malformation in young patient with cryptogenic stroke. JACC CardiovascInterv. 2013;6(5):e26-e27. https://doi.org/10.1016/j.jcin.2012.11.016.

116. Ishikawa Y., Yamanaka K., Nishii T., Fujii K., Rino Y., Maehara T. Videoassisted thoracoscopic surgery for pulmonary arteriovenous malformations: report of five cases. Gen Thorac Cardiovasc Surg. 2008;56(4):187–190. https://doi.org/10.1007/s11748-007-0215-6.

117. Nakamura H., Miwa K., Haruki T., Adachi Y., Fujioka S., Taniguchi Y. Pulmonary arteriovenous fistula with cerebral infarction successfully treated by video-assisted thoracic surgery. Ann Thorac Cardiovasc Surg. 2008;14(1):35–37. Available at: https://pubmed.ncbi.nlm.nih.gov/18292739/

118. Faughnan M., Palda V., Garcia-Tsao G., Geisthoff U., McDonald J., Proctor D. et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet. 2011;48:73–87. https://doi.org/10.1136/jmg.2009.069013.

119. Devlin H.L., Hosman A.E., Shovlin C.L. Antiplatelet and anticoagulant agents in hereditary hemorrhagic telangiectasia. N Engl J Med. 2013;368(9):876–878. https://doi.org/10.1056/NEJMc1213554.

120. Shovlin C.L., Millar C.M., Droege F., Kjeldsen A., Manfredi G., Suppressa P. et al. Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia. Orphanet J Rare Dis. 2019;14(1):210. https://doi.org/10.1186/s13023-019-1179-1.

121. Kleindorfer D.O., Towfighi A., Chaturvedi S., Cockroft K.M., Gutierrez J., Lombardi-Hill D. et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association / American Stroke Association. Stroke. 2021;52(7):e364-e467. https://doi.org/10.1161/STR.0000000000000375.

122. Baumgartner H., De Backer J., Babu-Narayan S.V., Budts W., Chessa M., Diller G.P. et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2021;42(6):563–645. https://doi.org/10.1093/eurheartj/ehaa554.

123. Shovlin C.L., Condliffe R., Donaldson J.W., Kiely D.G., Wort S.J. British Thoracic Society Clinical Statement on Pulmonary Arteriovenous Malformations. Thorax. 2017;72(12):1154–1163. https://doi.org/10.1136/thoraxjnl-2017-210764.